Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Molecular Oncology|December 15, 2015
Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapseClaudette Falato, Nicholas P Tobin, Julie Lorent, et al.
Frontiers in Oncology|December 19, 2022
Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysisYajing Zhu, Evangelos Tzoras, Alexios Matikas, et al.
BMC Cancer|October 15, 2013
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studiesJelena Milosevic, Johanna Klinge, Anna-Lena Borg, et al.
Cancer Chemotherapy and Pharmacology|July 24, 2014
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamideHans von Stedingk, Hanjing Xie, Thomas Hatschek, et al.
Breast Cancer Research and Treatment|August 18, 2014
Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancerClaudette Falato, Julie Lorent, Edneia Tani, et al.
Breast Cancer Research and Treatment|May 9, 2020
Chemotherapy use near the end-of-life in patients with metastatic breast cancerLuisa Edman Kessler, Johnny Sigfridsson, Dora Hatzidaki, et al.
Breast Cancer Research : BCR|March 8, 2024
Clinically relevant gene signatures provide independent prognostic information in older breast cancer patientsMiguel Castresana-Aguirre, Annelie Johansson, Alexios Matikas, et al.
Breast Cancer Research and Treatment|April 2, 2020
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancerYvonne Brandberg, Hemming Johansson, Mats Hellström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic DataAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Journal of Surgical Oncology|June 8, 2012
Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institutionIvan Segerhammar, Catharina Larsson, Inga-Lena Nilsson, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Molecular Oncology|December 15, 2015
Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapseClaudette Falato, Nicholas P Tobin, Julie Lorent, et al.
Frontiers in Oncology|December 19, 2022
Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysisYajing Zhu, Evangelos Tzoras, Alexios Matikas, et al.
BMC Cancer|October 15, 2013
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studiesJelena Milosevic, Johanna Klinge, Anna-Lena Borg, et al.
Cancer Chemotherapy and Pharmacology|July 24, 2014
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamideHans von Stedingk, Hanjing Xie, Thomas Hatschek, et al.
Breast Cancer Research and Treatment|August 18, 2014
Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancerClaudette Falato, Julie Lorent, Edneia Tani, et al.
Breast Cancer Research and Treatment|May 9, 2020
Chemotherapy use near the end-of-life in patients with metastatic breast cancerLuisa Edman Kessler, Johnny Sigfridsson, Dora Hatzidaki, et al.
Breast Cancer Research : BCR|March 8, 2024
Clinically relevant gene signatures provide independent prognostic information in older breast cancer patientsMiguel Castresana-Aguirre, Annelie Johansson, Alexios Matikas, et al.
Breast Cancer Research and Treatment|April 2, 2020
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancerYvonne Brandberg, Hemming Johansson, Mats Hellström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic DataAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Journal of Surgical Oncology|June 8, 2012
Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institutionIvan Segerhammar, Catharina Larsson, Inga-Lena Nilsson, et al.
Pageof 13